FDA RECALL MONSANTO MCT UNIT ORAL CONTRACEPTIVE NEW YORK MARCH 13 THE FOOD AND DRUG ADMINISTRATION SAID MONSANTO CO'S  MCT GD SEARLE AND CO UNIT IS VOLUNTARILY RECALLING ALL LOTS OF ITS GYNEX ORAL CONTRACEPTIVES THE FDA SAID SOME OF THE BLISTER PACK CARDS THAT HOUSE THE BIRTH CONTOL PILLS MAY CONTAIN OUT OF SEQUENCE TABLETS IN THE 28 DAY CYCLE PACKAGE IT SAID OTHER 21 DAY CYCLE PACKAGES MAY BE MISSING SOME TABLETS IF ORAL CONTRACEPTIVES ARE TAKEN IN THE WRONG ORDER OR SKIPPED THE LIKELIHOOD OF PREGANCY INCREASES THE FDA SAID SAID THE RECALL AFFECTS 315000 PACKAGES OF THE PILLS WHICH WERE DISTRIBUTED NATIONWIDE SINCE THE DRUG WAS FIRST DISTRIBUTED IN FEBRUARY THE FDA SAID SEARLE BELIEVES ONLY A SMALL NUMBER OF PACAKGES ABOUT 2000 TO 3000 WERE DISPENSED TO CONSUMERS THE FDA ALSO SAID THE LABELING ON THE PRODUCT INDICATES THAT GYNEX ORAL CONTRACEPTIVES ARE MANUFACTURED AND PACKAGED BY CORONA PHARMACEUTICAL OF CORONA CALIF FOR GD SEARLE AND CO   